Clinical trial
Dose Exploration in Patients With Atrial Fibrillation
NCT01227629 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose Exploration in Patients With Atrial Fibrillation
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2003
- Completion date
- Not reported
- Enrollment
- 502 (actual)
- Sites
- 38
Conditions
As the registry lists them; a condition with its own page is linked.